CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Back to CRIS

Emavusertib

Phase 2
CURIS INC (CRIS)

Phase 2

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts
What are catalysts?
Jul '27
CRISPhase 2

Emavusertib Phase 2 Est. Readout

Emavusertib
Jul 2027~
CT.gov
00%
Competitive Landscape

0 competitors in Acute Myelogenous Leukemia

View Full Landscape
Drug Information

Target Indication

Acute Myelogenous Leukemia

Clinical Trial

NCT04278768

Last updated: 2/15/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science
Mechanism of action & safety profile
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts

Weekly digest every Monday. Unsubscribe anytime.